Clinical trials
Terminated Demyelinating Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alexion Pharmaceuticals, Inc. | 2 |
| SwanBio Therapeutics, Inc. | 2 |
| Atara Biotherapeutics | 1 |
| Baylor Research Institute | 1 |
| Boston Scientific Corporation | 1 |
| Clene Nanomedicine | 1 |
| Novartis Pharmaceuticals | 1 |
| Shire | 1 |
| University Hospital, Bordeaux | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Demyelinating Diseases | 11 |
| Brain Diseases, Metabolic, Inborn | 3 |
| Hereditary Central Nervous System Demyelinating Diseases | 3 |
| Metabolic Diseases | 3 |
| Metabolism, Inborn Errors | 3 |
| Multiple Sclerosis | 3 |
| Multiple Sclerosis, Relapsing-Remitting | 3 |
| Nervous System Diseases | 3 |
| Adrenal Insufficiency | 2 |
| Adrenoleukodystrophy | 2 |
Trials
Showing 26 to 11 of 11. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.